In population pharmacokinetics, which of the following is a common covariate?

Get ready for the MDC Pharmacokinetics (PK) II Exam. Study with flashcards and multiple choice questions, each offering hints and explanations. Excel in your exam preparation!

Multiple Choice

In population pharmacokinetics, which of the following is a common covariate?

Explanation:
In population pharmacokinetics, covariates are patient characteristics that help explain differences in PK parameters across individuals. Weight, age, and organ function are classic covariates because they directly influence how a drug is distributed and eliminated. Body weight affects the volume of distribution and, through allometric scaling, clearance tends to change with size. Age captures maturation in children and potential changes with aging, which can alter clearance. Organ function, such as renal function for renal clearance or hepatic function for metabolism, directly reflects the body's capacity to eliminate drugs. These covariates are incorporated into PK models to improve predictions and account for variability among patients. In contrast, route of administration is a study design factor, and color or brand name don’t impact pharmacokinetics, so they aren’t covariates.

In population pharmacokinetics, covariates are patient characteristics that help explain differences in PK parameters across individuals. Weight, age, and organ function are classic covariates because they directly influence how a drug is distributed and eliminated. Body weight affects the volume of distribution and, through allometric scaling, clearance tends to change with size. Age captures maturation in children and potential changes with aging, which can alter clearance. Organ function, such as renal function for renal clearance or hepatic function for metabolism, directly reflects the body's capacity to eliminate drugs. These covariates are incorporated into PK models to improve predictions and account for variability among patients. In contrast, route of administration is a study design factor, and color or brand name don’t impact pharmacokinetics, so they aren’t covariates.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy